Participating Faculty

Supplements and Featured Publications, Biosimilars: Biologics That Meet Patients' Needs and Healthcare Economics, Volume 22, Issue 13

Publishing StaffEditorial & Production

Senior Vice President of Operations and Clinical Affairs

Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager

Ida Delmendo

Clinical Projects Manager

Cindy Spielvogel

Project Manager

Jessica Toye

Proofreaders

Griselda Demassey

Maggie Shaw

Associate Editor

Jeanne Linke

Assistant Editor

Sarah Anwar

Clinical Editor

Michael R. Page, PharmD, RPh

Designer

Sales & Marketing

Julianne Costello

Associate Publisher

Justin T. Gallagher

Director of Sales

Sara Belanger

National Account Managers

Gabrielle Consola

Operations & Finance

Michael CostellaVice President of Operations

Michael Pico

Vice President of Finance

Leah Babitz, CPA

Accountant

Kim Rotunno

Group Director, Circulation & Production

John Burke

Corporate

Chairman and CEO

Mike Hennessy, Sr

Vice Chairman

Jack Lepping

President

Mike Hennessy, Jr

Chief Financial Officer

Neil Glasser, CPA/CFE

Chief Marketing Officer

Warren Dardine

Chief Digital Strategy Officer

Steve Ennen

Vice President of Editorial Services and Production

Kerrie Keegan

Vice President, Digital Media

Jung Kim

Chief Creative Officer

Jeff Brown

Human Resource Director

Shari Lundenberg

FacultyMark McCamish, MD, PhD

Global Head

Biopharmaceutical Development

Sandoz Inc

Princeton, NJ

James McKay, PhD

Director

Clinical Development and Medical Affairs

Sandoz Inc

Princeton, NJ

William Yoon, PharmD, MBA

National Director

US Clinical Development and Medical Affairs

Sandoz Inc

Princeton, NJ

Faculty Disclosures

These faculty report relationships with the following organizations:

Mark McCamish, MD, PhD

Employment

Sandoz Inc

James McKay, PhD

Employment

Sandoz Inc

Expert testimony

State legislation on biosimilars

William Yoon, PharmD, MBA

Employment

Sandoz Inc

Expert testimony

State legislation on biosimilars

Meeting/conference attendance

Biosimilar conferences; panel expert

Stock/shareholder

Novartis